Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for

We identified a total of 14 studies with a low or medium risk of bias for use in our main network meta-analyses (NWMA) comparing the efficacy of drug therapies for early rheumatoid arthritis. Those findings are presented in our main report.

Chapter 11: Undertaking network meta-analyses

Bipartite network models to design combination therapies in acute myeloid leukaemia

Mapping the characteristics of network meta-analyses on drug therapy: A systematic review

Psych, Free Full-Text

BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses, BMC Medical Research Methodology

Frontiers A Network Meta-Analysis of the Dose–Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes

First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis - ScienceDirect

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

Sensitivity analysis of the network meta-analysis comparing the

Drug therapies for treatment of idiopathic pulmonary fibrosis: a systematic review, Bayesian network meta-analysis, and cost-effectiveness analysis - eClinicalMedicine

Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf

Psych, Free Full-Text